Peter Kolchinsky
5 additional roles and seats, 1 additional attributed investment
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Nothing material in the last 365 days. Last change: 26 Feb 2025, Sits on 4 boards on record, the latest Terrestrial Bio on 26 Feb 2025.
Roles
- RA Capital Management, LP Managing Partner? to present · “team page: Peter Kolchinsky / Managing Partner”Fact Firm website
Investments attributed to this person
| Company | Round | Investor | Attribution | Date | Source |
|---|---|---|---|---|---|
| Icosavax | Form D equity offering · $99.7M | RA Capital Management, LP | strongly supported · board | Apr 7, 2021 | Inference sec.gov |
| Calimmune | Form D equity offering · $15.9M | RA Capital Management, LP | strongly supported · board | May 28, 2015 | Inference sec.gov |
| Cellscape Corp | Form D equity offering · $1.1M | RA Capital Management, LP | strongly supported · board | Sep 10, 2012 | Inference sec.gov |
Board seats and vehicles
- Terrestrial Bio, Inc. Director Feb 26, 2025 Fact
- Icosavax board seat on a deal Apr 7, 2021 Inference
- Calimmune board seat on a deal May 28, 2015 Inference
- RA Capital Planetary Health Fund, LP Executive Officer Feb 9, 2024
- RA Capital Nexus Fund , L.P. Director/Promoter Jul 12, 2019
- RA Capital Nexus II Fund, L.P. Promoter Sep 29, 2020
Timeline
- Apr 7, 2021
- May 28, 2015
- Sep 10, 2012Form D equity offering in Cellscape Corp (RA Capital Management, LP)